Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

More articles from Original Article

  • Open Access
    High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer
    Yuling Xiao, Hang Zhang, Yi Xiao, Ying Wang, Jing Zhang, Qi Hua, Pengchen Hu, Xinyan Lyu, Weihua Shou, Xin Hu, Zhiming Shao, Yizhou Jiang, Wei Huang and Jinxiu Shi
    Cancer Biology & Medicine July 2025, 20250038; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0038
  • Open Access
    Beyond gold: the chemoenhancing mechanism and therapeutic potential of auranofin in melanoma
    Xiaofeng Wang, Yingnan Liu, Wuqiong Zhang, Zhongda Li, Su Li, Jiaxin Chen, Qi Li, Xiaoman Suo, Yanqiao Zeng, Guofang Zhang and Yang Li
    Cancer Biology & Medicine June 2025, 20250026; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0026
  • Open Access
    Plasma L-aspartic acid predicts the risk of gastric cancer and modifies the primary prevention effect: a multistage metabolomic profiling and Mendelian randomization study
    Mengyuan Wang, Zhouyi Yin, Hengmin Xu, Zongchao Liu, Sha Huang, Wenhui Wu, Yang Zhang, Tong Zhou, Weicheng You, Kaifeng Pan and Wenqing Li
    Cancer Biology & Medicine May 2025, 22 (5) 525-538; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0523
  • Open Access
    Nuclear PHGDH regulates macrophage polarization through transcriptional repression of GLUD1 and GLS2 in breast cancer
    Pei Wang, Xin Du, Zhiren Han, Jiaxin Zhong, Jiayu Yuan, Lin Jiang, Beinan Han, Wenkui Fu, Hongde Li, Hai Hu and Zhenkun Na
    Cancer Biology & Medicine May 2025, 22 (5) 502-524; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0398
  • Open Access
    Mitochondrial transplantation sensitizes chemotherapy to inhibit tumor development by enhancing anti-tumor immunity
    Shumeng Lin, Liuliu Yuan, Xiao Chen, Shiyin Chen, Mengling Wei, Bingjie Hao, Tiansheng Zheng and Lihong Fan
    Cancer Biology & Medicine June 2025, 20240596; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0596
  • Open Access
    Cancer cell-derived migrasomes harboring ATF6 promote breast cancer brain metastasis via endoplasmic reticulum stress-mediated disruption of the blood-brain barrier
    Song Wang, Guohao Gu, Xinmiao Xian, Jun Li, Di Zhang, Jianran Guo, Anqi Zhang, Shen Chen, Dong Yan, Bingwu Yang, Meng An, Wei Zhang and Bo Fu
    Cancer Biology & Medicine June 2025, 20250014; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0014
  • Open Access
    Cancer-derived exosomal circTMEM56 enhances the efficacy of HCC radiotherapy through the miR-136-5p/STING axis
    Li Yuan, Yue Wang, Junjie Cheng, Shilin Lin, Aying Ma, Kunchao Li, Yiming Zheng, Zhaochong Zeng, Aiwu Ke, Chao Gao and Shisuo Du
    Cancer Biology & Medicine April 2025, 22 (4) 396-411; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0544
  • Open Access
    IL-33/ST2 signalling promotes tumor growth by regulating polarization of alternatively activated macrophages
    Liping Liu, Haoge Luo, Yingdong Xie, Ying Wang, Shiying Ren, Haiyang Sun and Dong Li
    Cancer Biology & Medicine April 2025, 22 (4) 376-395; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0483
  • Open Access
    Neoepitope BTLAP267L-specific TCR-T cell immunotherapy unlocks precision treatment for hepatocellular carcinoma
    Fang Liu, Hua Chen, Suxin Wu, Chenlu Zhu, Mingji Zhang, Wei Rui, Dong Zhou, Yang Wang, Xin Lin, Xueqiang Zhao and Yunbin Ye
    Cancer Biology & Medicine April 2025, 22 (4) 412-432; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0434
  • Open Access
    Optimal immunotherapy duration in advanced NSCLC: defining the ideal treatment window
    Kaibo Ding, Dujiang Liu, Xinyue Li, Zhongsheng Peng, Lin Zhu and Yanjun Xu
    Cancer Biology & Medicine March 2025, 22 (3) 284-294; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0457

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 42

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire